USPTO serial 79264750
SANSTEMZA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 28, 2020
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SANSTEMZA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Howard N. Aronson
Howard N. Aronson Lackenbach Siegel LLP1 Chase Rd.Lackenbach Siegel Bldg.Scarsdale, NY 10583-4156Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Stem cells for medical and veterinary purposes; cells for medical and clinical use; living cells for medical purposes; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of traumatic brain injury, cerebral infarction, cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury, and Alzheimer's disease; biological implants, namely, a vital processed human or animal connective tissue; surgical implants grown from stem cells; implants comprising living tissue; living tissue transplants in the nature of vascular grafts; human allograft tissues; processed human donor skins for the replacement of soft tissue | ACTIVE | — |
| 010 | Apparatus for the regeneration of stem cells for medical purposes; medical apparatus and instruments used for cell culture, namely, for cell culture chambers; medical apparatus and instruments, namely, cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; medical apparatus and instruments, namely, intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; medical apparatus and instruments for analyzing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; medical apparatus and instruments, namely, test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; medical apparatus and instruments, namely, apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; and medical apparatus and instruments, namely, cell injector for medical purposes in the nature of injection instrument with needles; medical apparatus and instruments, namely, needle-based and needle-free injection systems; implants consisting of artificial materials; artificial implants in the nature of surgical implants comprised of artificial materials and artificial vascular grafts | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SanBio Company Limited
- Other trademarks owned by SanBio Company Limited
- Other trademarks owned by SanBio Company Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named SANSTEMZA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 28, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 6, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 15, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 15, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 28, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 28, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 12, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 31, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 24, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 11, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 11, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 27, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |